Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Clinical trial NCT00192621 · COMPLETED

Trial details

NCT number: NCT00192621
Sponsor: Kirby Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Infections Dyslipidemias Glucose Metabolism Disorders Metabolic Diseases Lipodystrophy Cardiovascular Disease

Start date: 2004-11-01
Primary completion: 2006-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.